Biolevate

Biolevate is a Paris-based life sciences AI startup founded in 2023 by Joel Belafa and Nathan Chen. Its core product, the ELISE knowledge platform, uses NLP and visual document reading to extract and structure unstructured healthcare and regulatory data. The platform targets pharmaceutical, MedTech and cosmetics companies, offering metadata extraction, collaborative editing, version control and regulatory-compliant workflows to accelerate R&D and regulatory submissions.

  • AI/ML
  • NLP
  • Biotechnology
  • Healthtech
  • Medtech
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Sep 21, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Sep 21, 2026

    EUR 30M

    Series A

    Led by Aymar Hénin

    • Aymar Hénin

    Article coming soon.

Pricing

Research Biolevate — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Biolevate is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational